San Diego Blood Donors Get Free Genome Sequencing
By David Wagner,
KPBS
| 11. 24. 2015
Untitled Document
A select group of blood donors at this year's Chargers Blood Drive gave one extra tube of blood. That's because they're not just donating blood — they're also getting their genome sequenced.
San Diego-based Illumina is providing free sequencing to 70 San Diego Blood Bank donors. The Blood Bank's goal is to compile a DNA database for researchers to comb through in hopes of pinpointing genes linked with health outcomes.
La Mesa resident Penelope Navarro was one of the pre-selected participants. She signed up to learn about the diseases her family may need to look out for.
"I'm a breast cancer survivor," Navarro said. "And I have children and grandchildren. So I thought an experience like this would help in perhaps finding out whether or not that's something they might need to be looking into as they grow older."
By participating, Navarro agreed to provide her DNA for research purposes, letting scientists search her genes for correlations with diseases like breast cancer. She'll also be able to access her genome online and learn more about it at an...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Robert Resta, The DNA Exchange | 07.22.2024
Medical geneticists and genetic counselors have an often complicated and at times tense relationship with people with disabilities, their families, advocates, and scholars. Geneticists are strong advocates and supporters for all of their patients, regardless of their abilities and disabilities...
By Katherine Bourzac, Nature | 07.10.2024
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...